SRC-3 treatment decreased tumor growth in a Jeko-1 ibrutinib resistant mouse model. حسب Imani Bijou (18275174)

Excel spreadsheet containing, in separate sheets, the underlying numerical data and statistical analysis for Figure panels 1A-1D, 2D-2H, 3B, 4B, 4C, 4E, 5D, 5F, 5G, 5I-5M, 6A-6D, 6... حسب Yuru Wang (846969)

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. حسب Rozita Mohd (7411322)

Pestones A and B from a Fungus <i>Pestalotiopsis</i> sp. Bound to Mutant p53 and Changed Its Conformation حسب Yusaku Sadahiro (8725830)

"…Compound <b>1</b> was found to induce apoptosis in Saos-2 (p53^R175H) cells by flow cytometry analysis and decreased tumor growth <i>in vivo</i> using a mouse model with HuCCT1 (p53^R175H) cells.…"

Pathogenicity of LCLs in 5-week-old NOG mice. حسب Ken Sagou (1945318)

Binding of compound 16 with DNA-Topo II complex. حسب Ahmed A. Gaber (13302308)

الموضوعات:

General procedure for the synthesis of the target compounds 16–20. حسب Ahmed A. Gaber (13302308)

الموضوعات:

Barbie’s ankle equinus measured at 50 degrees as equnius posture (a) and flat foot posture measured at 0 degrees (b), with a handheld goniometer. حسب Cylie Williams (3446018)

Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs. حسب Yang Zhang (30734)

Proportion of CD25⁺CD16^low cells among CD3^-CD11b⁺ cells according to the dose of anti-thymocyte globulin. حسب Youngmin Ko (3333819)

A mechanism of non-target site resistance conferred by loss-of-function of <i>PAM16</i> is conserved in <i>M</i>. <i>polymorpha</i>. حسب Chloe Casey (14341756)

الموضوعات:

M344 decreases orthotopic pancreatic tumor growth when used as a treatment alone or in combination with gemcitabine. حسب Shelby M. Knoche (13833807)

Biochar decreases nutrient leaching in KCl-fertilized Podzols grown with black mucuna حسب Luciana Aparecida Rodrigues (7291115)

Affinity analysis results (with a confidence level above 50%). حسب Marta R. Jabłońska (8491404)

Comparison of residual stresses between RS16 and B29. حسب Yihan Tu (22258445)

Disrupting Glycolysis-promoting Genes Extends <i>C</i>. <i>elegans</i> Healthspan, Whereas High Glucose and Gluconeogenic Gene Disruptions Shorten Healthspan. حسب Brian Onken (86790)

"…Trials with 5 and 13 day old animals also showed impaired older age locomotion in 4% glucose (Supplemental <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.s002" target="_blank">S1A and S1B Fig</a>). …"

Dietary Restriction Induces Gluconeogenic Gene <i>pck-2</i> Expression via DAF-16, and <i>pck-2</i> Expression is Needed for DR-associated Healthspan Benefits. حسب Brian Onken (86790)

"…Elevated gluconeogenic activity (dependent on DAF-16-promoted PCK-2 expression) acts in a feed-forward capacity to further enhance the gluoconeogenic pathway and may inhibit glycolysis/insulin signaling to promote/maintain DAF-16 signaling and healthy metabolism (inhibition represented by a dashed line).…"

Association between CVR components^b'*' and depressive status (BDI-II ≥18) in the PREDIMED-PLUS trial. حسب Sandra Martín-Peláez (11353470)

الموضوعات:

Baseline characteristics of the study participants. حسب Sandra Martín-Peláez (11353470)

الموضوعات:

Flow chart for the analysis of cardiovascular risk and depression in the PREDIMED-PLUS trial. حسب Sandra Martín-Peláez (11353470)

الموضوعات: